Concepedia

S Hanák

SH

4

Publications

156

Citations

4

H-Index

2000

Active since

Affiliations

Sanofi (United States)(Current)

CNS Research (United States)

S Hanák is an author at Sanofi (United States) specializing in medicine, neuroscience, and neuropharmacology.

Top concepts

Publications per year

2000–2013

4

Publications

4

Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis

Jean E. Merrill, S Hanák, Su-Fen Pu et al. · Journal of Neurology · 2009 · 110 citations

, , +12

Effects of Prophylactic and Therapeutic Teriflunomide in Transcranial Magnetic Stimulation–Induced Motor-Evoked Potentials in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis

Deborah Iglesias-Bregna, S Hanák, Zhongqi Ji et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 21 citations

Effect of AMPA receptor modulators on hippocampal and cortical function

Mark D. Black, Jill Wotanis, Donald E. Schilp et al. · European Journal of Pharmacology · 2000 · 15 citations

, , +11

Comparative analysis of acute and chronic administration of haloperidol and clozapine using [3H] 2-deoxyglucose metabolic mapping

Jill Wotanis, S Hanák, Joseph G. Wettstein et al. · Schizophrenia Research · 2003 · 10 citations

, , +7

Rows per page

1–4 of 4